pyrazines has been researched along with Hyperuricemia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doi, Y; Iwasaki, H; Koseki, T; Mizuno, T; Nakajima, K; Takahashi, K; Yamada, S | 1 |
| Abdelaal, AH; Abozaid, AA; Ads, AM; Alhijazeen, S; Aziz, JMA; Ghula, S; Hirayama, K; Hung, DT; Huy, NT; Ibrahim, AM; Iiyama, T; Karmally, Z; Kita, K; Kouz, B; Le, TN; Makram, AM; Nakhare, S; Nam, NH; Pancharatnam, RA; Phuong, NQ; Shabouk, MB; Tawfik, GM; Turnage, M | 1 |
| Abe, T; Anzai, N; Mishima, E; Miyazaki, M | 1 |
| Hase, R; Ishida, K; Kurata, R; Kurita, T; Mito, H; Muranaka, E | 1 |
| Banno, S; Doi, Y; Hase, R; Hibino, M; Hirose, M; Homma, Y; Horiguchi, T; Ikeda, N; Imai, T; Iwata, M; Kabata, D; Kamio, T; Kasahara, H; Kasamatsu, Y; Kashizaki, F; Kato, H; Kato, Y; Kita, T; Koba, H; Kodama, N; Kondo, M; Koseki, T; Lim, CK; Maeki, T; Matsuyama, A; Miyata, M; Mutoh, Y; Nakagawa, A; Nakatsumi, H; Nakayama, E; Ogawa, T; Saijo, M; Shinoda, M; Shintani, A; Tajima, S; Taniguchi, S; Terada, M; Teramachi, M; Uchida, Y; Yamamoto, M; Yokota, K; Yokoyama, T; Yoshida, H; Yoshida, J; Yuzawa, Y | 1 |
2 review(s) available for pyrazines and Hyperuricemia
| Article | Year |
|---|---|
The efficacy and adverse effects of favipiravir on patients with COVID-19: A systematic review and meta-analysis of published clinical trials and observational studies.
Topics: Amides; COVID-19 Drug Treatment; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hyperuricemia; Pyrazines; SARS-CoV-2; Treatment Outcome | 2022 |
Uric Acid Elevation by Favipiravir, an Antiviral Drug.
Topics: Aldehyde Oxidase; Amides; Antiviral Agents; Biotransformation; Coronavirus Infections; COVID-19; Drug Interactions; Humans; Hyperuricemia; Kidney; Kidney Diseases; Molecular Structure; Organic Anion Transport Protein 1; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Organic Cation Transport Proteins; Pandemics; Pneumonia, Viral; Pyrazines; Uric Acid; Xanthine Oxidase | 2020 |
1 trial(s) available for pyrazines and Hyperuricemia
| Article | Year |
|---|---|
A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19.
Topics: Adolescent; Adult; Amides; Antiviral Agents; Asymptomatic Diseases; COVID-19; COVID-19 Drug Treatment; Female; Hospitalization; Humans; Hyperuricemia; Japan; Male; Middle Aged; Prospective Studies; Pyrazines; Random Allocation; SARS-CoV-2; Secondary Prevention; Severity of Illness Index; Time-to-Treatment; Treatment Outcome; Viral Load | 2020 |
2 other study(ies) available for pyrazines and Hyperuricemia
| Article | Year |
|---|---|
Baseline uric acid levels and steady-state favipiravir concentrations are associated with occurrence of hyperuricemia among COVID-19 patients.
Topics: Amides; COVID-19; Humans; Hyperuricemia; Pyrazines; SARS-CoV-2; Uric Acid | 2022 |
Acute Gouty Arthritis During Favipiravir Treatment for Coronavirus Disease 2019.
Topics: Adult; Amides; Antiviral Agents; Arthritis, Gouty; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Hyperuricemia; Lung; Male; Pandemics; Pneumonia, Viral; Pyrazines; SARS-CoV-2; Uric Acid | 2020 |